News headlines about (NYSE:CRCM) have trended somewhat positive on Saturday, Accern reports. Accern scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. earned a news impact score of 0.10 on Accern’s scale. Accern also assigned news headlines about the information services provider an impact score of 44.3285362790358 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

These are some of the headlines that may have effected Accern’s scoring: (NYSE CRCM) traded up 0.51% during midday trading on Friday, hitting $15.89. The company had a trading volume of 181,287 shares. The company’s 50 day moving average is $14.80 and its 200 day moving average is $13.96. has a 12-month low of $7.51 and a 12-month high of $16.50. The stock has a market cap of $473.03 million, a price-to-earnings ratio of 635.60 and a beta of 0.92. (NYSE:CRCM) last announced its earnings results on Thursday, August 10th. The information services provider reported $0.11 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.04) by $0.15. had a return on equity of 10.98% and a net margin of 3.66%. The firm had revenue of $42.00 million for the quarter, compared to analysts’ expectations of $41.34 million. During the same quarter in the previous year, the company earned ($0.03) earnings per share. The firm’s quarterly revenue was up 9.9% compared to the same quarter last year. On average, equities analysts anticipate that will post $0.40 EPS for the current fiscal year.

CRCM has been the subject of a number of analyst reports. Zacks Investment Research raised from a “hold” rating to a “buy” rating and set a $17.00 target price for the company in a research note on Wednesday, July 12th. Stifel Nicolaus upped their price target on from $12.00 to $14.00 and gave the stock a “buy” rating in a report on Friday, August 11th. Roth Capital set a $14.00 price target on and gave the stock a “hold” rating in a report on Thursday, August 10th. Finally, BidaskClub upgraded from a “sell” rating to a “hold” rating in a report on Thursday, August 10th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company’s stock. has a consensus rating of “Hold” and a consensus target price of $15.00.

ILLEGAL ACTIVITY NOTICE: This story was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright law. The legal version of this story can be read at

In other news, General Counsel Diane Musi sold 2,000 shares of the company’s stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $14.70, for a total value of $29,400.00. Following the transaction, the general counsel now owns 32,593 shares of the company’s stock, valued at $479,117.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider David Krupinski sold 3,326 shares of the company’s stock in a transaction on Tuesday, September 12th. The shares were sold at an average price of $14.56, for a total value of $48,426.56. Following the completion of the transaction, the insider now directly owns 176,128 shares in the company, valued at approximately $2,564,423.68. The disclosure for this sale can be found here. In the last three months, insiders have sold 24,673 shares of company stock worth $360,728. 24.70% of the stock is owned by corporate insiders.

About, Inc is an online marketplace for finding and managing family care. As of December 31, 2016, the Company had 22.8 million members, including 12.9 million families and 9.9 million caregivers, spanning 19 countries. Its consumer matching solutions allow families to search for, qualify, vet, connect with and select caregivers.

Insider Buying and Selling by Quarter for (NYSE:CRCM)

Receive News & Stock Ratings for Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inc. and related stocks with our FREE daily email newsletter.